Introduction {#s0005}
============

Uncoupling proteins (UCP), a member of mitochondrial membrane transporters, were considered to be associated with energy homeostasis ([@bb0015]). The UCP2, which is widely expressed in human tissues and serves as an uncoupler of oxidative phosphorylation, is involved in the regulation of lipid metabolism and ATP production ([@bb0030], [@bb0250]). It has been reported that impaired expression of UCP2 mRNA in adipose tissue may be responsible for the pathophysiology of obesity ([@bb0155]). Ala55Val (rs660339) in Exon 4, 45-bp insertion/deletion in Exon 8, and -866G/A (rs659366) in the promoter region, have been considered as the most interesting polymorphisms in *UCP2* gene. The -866G/A and 45-bp insertion/deletion polymorphisms were found to be functional on mRNA expression ([@bb0035], [@bb0085]). A variant allele of the Ala55Val polymorphism was reported to be associated with lower 24-h energy expenditure ([@bb0010]). Associations of the three polymorphisms with the risk of overweight and obesity have been widely evaluated, but the conclusions remain controversial. In the present study, we performed a meta-analysis to assess the effect of *UCP2* Ala55Val, 45-bp insertion/deletion, and -866G/A polymorphisms on the risk of overweight and obesity.

Methods {#s0010}
=======

Search strategy {#s0015}
---------------

Relevant articles published in English and Chinese were searched from five databases: (1) PubMed (1990--2013); (2) Web of Science (ISI) (1990--2013); (3) China National Knowledge Infrastructure (CNKI) (1990--2013); (4) Database of Chinese Scientific and Technical Periodicals (VIP) (1990--2013); and (5) China Biology Medical literature database (CBM) (1990--2013). The search strategy involved the following keywords: 'uncoupling protein 2', 'UCP2', 'polymorphism', 'obesity', 'adiposity', 'obese', and 'overweight'. References of the retrieved articles were checked for additional studies. The literature search was updated on February 22, 2013.

Eligibility criteria {#s0020}
--------------------

A study that met the following criteria was included in the meta-analysis: (1) case--control, cohort study, or cross-sectional studies which evaluated the association of *UCP2* gene polymorphisms with overweight and obesity; (2) provided sufficient data of genotypes in case (exposed) and control (unexposed) groups; (3) subjects were recruited from the same ethnicity during the same period; (4) if data were repetitively reported, the most complete one was included; (5) the genotype distribution of the controls obey Hardy--Weinberg equilibrium (HWE). The articles were independently assessed by two authors. Disagreements were resolved by consensus with a third reviewer.

Data extraction {#s0025}
---------------

Information of the studies was extracted by two independent authors, including first author, publication year, location, ethnicity of subjects, sample size, frequencies of genotype and allele, percentage of male subjects and mean age of subjects in case (exposed) and control (unexposed) groups.

Statistical analysis {#s0030}
--------------------

HWE for *UCP2* Ala55Val, 45-bp insertion/deletion, and -866G/A genotype distributions in controls was tested using Pearson χ^2^ test. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the associations of the *UCP2* Ala55Val, 45-bp insertion/deletion, and -866G/A polymorphisms with risk of overweight and obesity under dominant (CT+TT vs. CC for Ala55Val, ID+II vs. DD for 45-bp insertion/deletion, and GA+AA vs. GG for -866G/A), recessive (TT vs. CT+CC for Ala55Val, II vs. ID+DD for 45-bp insertion/deletion, and AA vs. GA+GG for -866G/A), co-dominant 1 (CT vs. CC for Ala55Val, ID vs. DD for 45-bp insertion/deletion, and GA vs. GG for -866G/A), co-dominant 2 (TT vs. CC for Ala55Val, II vs. DD for 45-bp insertion/deletion, and AA vs. GG for -866G/A), additive (2TT+CT vs. CC for Ala55Val, 2II+ID vs. DD for 45-bp insertion/deletion, and 2AA + vs. GG for -866G/A), over-dominant (CT vs. CC+TT for Ala55Val, ID vs. II+DD for 45-bp insertion/deletion, and GA vs. AA+GG for -866G/A) and allelic (T vs. C for Ala55Val, I vs. D for 45-bp insertion/deletion, and A vs. G for -866G/A) models, respectively. Pooled ORs in subgroups stratified by ethnicity were also calculated. In addition, cumulative analyses were performed to track the evidence over sample size. *Z* test was used to determine the significance of pooled OR. The *I^2^* was used to assess heterogeneity among studies ([@bb0065]). Heterogeneity was considered significant if *I^2^* \> 50%, when random-effect model (REM) was adopted as the pooling method; otherwise, fix-effect model (FEM) was used. Meta-analysis regression was performed to identify potential covariates, including ethnicity, publication year, sex, age and sample size, which may contribute to between-study heterogeneity. Sensitive analysis was performed to identify 'outlying' studies and decrease statistical heterogeneity if *I^2^* \> 50% using *hetred* module ([@bb0175]). Influence of each individual study on the pooled estimate was investigated with influence analysis. A study was suspected of excessive influence if the point estimate of its omitted meta-analysis was beyond the 95%CI of the full analysis. Publication bias was evaluated by funnel plot and Peters test ([@bb0180]). All statistical analyses were performed with STATA version 11.0 (Stata Corporation, College Station, TX, USA). *P* value \< 0.05 was considered statistically significant (two-tailed).

Results {#s0035}
=======

Characteristics of studies {#s0040}
--------------------------

A total of 37 published articles with 42 studies ([@bb0005], [@bb0020], [@bb0025], [@bb0035], [@bb0040], [@bb0045], [@bb0055], [@bb0060], [@bb0070], [@bb0080], [@bb0090], [@bb0095], [@bb0100], [@bb0105], [@bb0110], [@bb0115], [@bb0125], [@bb0130], [@bb0135], [@bb0140], [@bb0150], [@bb0160], [@bb0165], [@bb0170], [@bb0185], [@bb0190], [@bb0195], [@bb0200], [@bb0205], [@bb0210], [@bb0220], [@bb0225], [@bb0230], [@bb0235], [@bb0240], [@bb0245], [@bb0255]) were eligible for this meta-analysis, including 12 studies on Ala55Val (2011 cases and 2752 controls), 12 studies on 45-bp insertion/deletion (3416 cases and 3260 controls), and 18 studies on -886G/A (5780 cases and 10,196 controls). General characteristics and genotype distributions of the three polymorphisms were summarized in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}. In the Asian population, the average frequency of T allele in Ala55Val polymorphism was 38.5% in cases and 41.5% in controls, that of I allele in 45-bp insertion/deletion polymorphism was 12.3% in cases and 11.9% in controls, and that of A allele in -866G/A polymorphism was 41.0% in cases and 44.7% in controls. In the European population, the average frequency of T allele in Ala55Val polymorphism was 53.1% in cases and 51.7% in controls, that of I allele in 45-bp insertion/deletion polymorphism was 27.8% in cases and 27.0% in controls, and that of A allele in -866G/A polymorphism was 37.3% in cases and 39.3% in controls.

Quantitative synthesis {#s0045}
----------------------

The results of pooled analyses were summarized in [Table 4](#t0020){ref-type="table"}.

### UCP2 Ala55Val polymorphism {#s0050}

In the overall population, T allele was found to be significantly associated with an increased risk of overweight and obesity in the recessive (FEM: OR = 1.24, 95%CI = 1.06--1.45), co-dominant 2 (REM: OR = 1.38, 95%CI = 1.03--1.84), additive (REM: OR = 1.34, 95%CI = 1.04--1.72), and allelic (REM: OR = 1.25, 95%CI = 1.07--1.48) models.

Subgroup analysis stratified by ethnicity revealed a significant association in recessive (FEM: OR = 1.28, 95%CI = 1.06--1.55), co-dominant 2 (REM: OR = 1.50, 95%CI = 1.01--2.20), additive (REM: OR = 1.41, 95%CI = 1.04--1.93) and allelic (REM: OR = 1.32, 95%CI = 1.07--1.63) models for Asians. No significant association between Ala55Val polymorphism and risk of overweight and obesity was found in any of the models for Europeans. The pooled ORs for the association of Ala55Val polymorphism with overweight and obesity under recessive model in the main and cumulative meta-analysis were presented in [Fig. 1](#f0005){ref-type="fig"}.

### UCP2 45-bp insertion/deletion polymorphism {#s0055}

The meta-analysis showed no significant association between the 45-bp insertion/deletion polymorphism and the risk of overweight and obesity in dominant (FEM: OR = 1.02, 95%CI = 0.92--1.13), recessive (FEM: OR = 1.19, 95%CI = 0.95--1.49), co-dominant 1 (FEM: OR = 1.00, 95%CI = 0.89--1.12), co-dominant 2 (FEM: OR = 1.16, 95%CI = 0.92--1.46), additive (REM: OR = 1.04, 95%CI = 0.93--1.15), over-dominant (FEM: OR = 0.98, 95%CI = 0.88--1.09) and allelic (REM: OR = 1.02, 95%CI = 0.89--1.17) models. The results remained non-significant after stratification by ethnicity. The pooled ORs for the association of 45-bp insertion/deletion polymorphism with overweight and obesity under dominant model in the main and cumulative meta-analysis were presented in [Fig. 2](#f0010){ref-type="fig"}.

### UCP2 -866G/A polymorphism {#s0060}

In the overall population, no significant association between -866G/A polymorphism and risk of overweight and obesity was found in any of the models. Subgroup analysis stratified by ethnicity revealed significant associations in dominant (FEM: OR = 0.88, 95%CI = 0.81--0.96), co-dominant 1 (FEM: OR = 0.89, 95%CI = 0.81--0.98), co-dominant 2 (FEM: OR = 0.85, 95%CI = 0.74--0.94), additive (FEM: OR = 0.88, 95%CI = 0.80--0.95), and allelic (FEM: OR = 0.91, 95%CI = 0.86--0.97) models for Europeans. However, no significant association was found in any inherited models in the population of Asian descent. The pooled ORs for the association of -866G/A polymorphism with overweight and obesity under dominant model in the main and cumulative meta-analysis were presented in [Fig. 3](#f0015){ref-type="fig"}.

Source of heterogeneity and sensitive analysis {#s0065}
----------------------------------------------

As shown in [Table 4](#t0020){ref-type="table"}, significant heterogeneity (*I^2^* \> 50%) was observed among studies of the Ala55Val, 45-bp insertion/deletion, and -866G/A polymorphisms in some inherited models. Univariate meta-regression with the covariates of ethnicity, publication year, sex (ratio of male in case group to that in control group) and age (ratio of mean age in case group to that in control group) revealed that no covariates had excessive influence on between-study heterogeneity regarding the association of each polymorphism with overweight and obesity.

Significant heterogeneity was observed among studies of the Ala55Val polymorphism under all the inherited models except for the recessive one in the overall population. When stratified by ethnicity, the heterogeneity still existed in participants of Asian descent. Studies that were key contributors to between-study heterogeneity were indicated in [Table 4](#t0020){ref-type="table"}. After sensitive analysis, the associations between T allele and risk of overweight and obesity were no longer significant in the co-dominant 2, additive, and allelic inherited models among the overall population.

Significant heterogeneity was observed among studies regarding the associations of the 45-bp insertion/deletion polymorphism with overweight and obesity in additive and allelic models among the overall population. When stratified by ethnicity, the heterogeneity was significantly decreased in the population of Asian descent, but still existed in that of European descent. Results of sensitive analysis indicated that one study ([@bb0040]) was mainly responsible for the between-study heterogeneity in additive and allelic models for the overall population, and that in dominant, co-dominant 2, additive and allelic models for the population of European descent, considering the association of the 45-bp insertion/deletion polymorphism with overweight and obesity. After exclusion of the study, the associations still remained non-significant in all the inherited models.

Significant heterogeneity was observed among studies regarding the associations of the -866G/A polymorphism with overweight and obesity in dominant, co-dominant 2, additive, and allelic models among the overall population. When stratified by ethnicity, the heterogeneity was significantly decreased in the population of European descent, but still existed in that of Asian descent. After sensitive analysis, the associations between A allele and risk of overweight and obesity were significant in the co-dominant 2 (FEM: OR = 0.99, 95%CI = 0.80--0.98) and allelic (FEM: OR = 0.94, 95%CI = 0.89--0.99) models in the overall population. However, the associations remained non-significant in all the aforementioned inherited models among the population of Asian descent.

Influence analysis {#s0070}
------------------

With articles that were key contributors to heterogeneity being excluded, no individual study was found to have excessive influence on the pooled effect under all the mentioned inherited models for any of the polymorphisms (data not shown).

Publication bias evaluation {#s0075}
---------------------------

After exclusion of studies that were key contributors to between-study heterogeneity, no publication bias was detected in all the aforementioned inherited models using funnel plot and Peters test regarding the associations between the three polymorphisms with overweight and obesity (data not shown).

Discussion {#s0080}
==========

*UCP2* gene was first identified as a candidate gene for obesity by [@bb0050]. Since then, the associations of *UCP2* gene polymorphisms (Aal55Val, 45-bp insertion/deletion, and -866G/A) with overweight and obesity have been widely studied; however, the results were conflicting. Considering the small effect of a genetic variant, a large sample size is certainly required in the primary genetic association study with adequate power. In order to obtain a robust conclusion regarding the role of *UCP2* gene polymorphisms in the risk of overweight and obesity based on a larger scale of population, we performed the meta-analyses consisting 42 studies to evaluate the associations. The pooled ORs from our meta-analyses revealed a risk effect of T allele in Ala55Val polymorphism in populations of Asian descent, a protective effect of A allele in -866G/A polymorphism in populations of European descent and no effect of 45-bp insertion/deletion polymorphism on overweight and obesity. Cumulative meta-analyses showed an increased accuracy in the estimate of effects with larger samples aggregated for the three polymorphisms in *UCP2* gene.

Between-study heterogeneity is a usual concern in meta-analyses ([@bb0145]), which was also observed in our analysis under most of the inherited models regarding the association of *UCP2* polymorphisms with overweight and obesity. After stratification analysis by ethnicity, the heterogeneity in some comparison groups remained significant. To further explore the source of heterogeneity, we performed a meta-regression analysis involving covariates such as publication year, sex, age, and sample size. However, none of the covariates was found to contribute to the between-study heterogeneity regarding the associations of aforementioned polymorphisms with overweight and obesity. It suggested that some other confounding factors, such as design quality, representativeness and general characteristics of the participants, environmental exposures, and non-uniform genotyping methods may be responsible for the heterogeneity. However, we failed to evaluate the role of these factors in the source of heterogeneity in our analysis due to inadequate information in the original articles.

No significant between-study heterogeneity (*I^2^* \< 50) was found in the recessive model regarding the association of Ala55Val polymorphism with overweight and obesity. Available data suggested a stable association of T allele of Ala55Val polymorphism with an increased risk of overweight and obesity in the recessive model for the Asian population. Studies indicated that the Ala55Val polymorphism had effects on metabolic rate and nocturnal physical activity ([@bb0010], [@bb0075], [@bb0215]). T allele of the polymorphism was reported to be associated with lower energy expenditure and lower fat oxidation ([@bb0010]), which may be implicated in the pathogenesis of overweight and obesity. In this meta-analysis, we failed to fully explore the source of between-study heterogeneity observed in most of the inherited models. Although significant associations were revealed in the co-dominant 2, additive and allelic models in the meta-analysis, the conclusions were limited because of the unsolved heterogeneity.

Significant between-study heterogeneity was found in the additive and allelic models regarding the association of 45-bp insertion/deletion polymorphism with overweight and obesity in the overall population. One study ([@bb0040]) that was a key contributor to the heterogeneity was identified using sensitive analysis. The between-study heterogeneity largely decreased after the key contributor was excluded, and the conclusions were consistent with those before sensitive analysis. In our meta-analysis, no evidence was observed on the association of *UCP2* 45-bp insertion/deletion polymorphism with overweight and obesity both in European and Asian populations.

Associations of -866G/A polymorphism with the risk of obesity were evaluated using meta-analysis by [@bb0005] and [@bb0120] before. In this study, we performed a meta-analysis based on 15,976 individuals from 18 studies with strict eligible criteria to provide robust evidence. Available data in our meta-analysis suggested a stable association of -866G/A polymorphism with overweight and obesity in the population of European descent. The pooled ORs for GA+AA vs. GG, GA vs. GG, AA vs. GG and A vs. G for Europeans were 0.88, 0.89, 0.85 and 0.91, respectively, which were consistent with previous researches ([@bb0005], [@bb0120]). Besides, we identified a significant association of -866G/A polymorphism with overweight and obesity under additive model (2AA+GA vs GG) for the population of European descent. However, no evidence was observed in all the aforementioned models for the population of Asian descent. Oberkofler et al. indicated a reduced *UCP2* mRNA level in intraperitoneal adipose tissue in obese individuals ([@bb0155]). A allele of -866G/A polymorphism was reported to be associated with enhanced *UCP2* mRNA expression in adipose tissue in European population ([@bb0035]), which may explain its protective effect against overweight and obesity.

Obesity is a heterogeneous disorder caused by complex gene × gene and gene × environment interactions. The effects of Ala55Val and -866G/A polymorphisms on overweight and obesity differed in Europeans and Asians, which may be attributed to different genetic backgrounds. Significant linkage disequilibrium has been observed among Ala55Val, 45-bp insertion/deletion, and -866G/A polymorphisms in overweight and obese populations ([@bb0035], [@bb0160], [@bb0165], [@bb0220]). Lack of consideration of the effects of adjacent loci may partially explain the discrepancies among individual studies. Since limited information was provided in the included studies, effects of haplotypes on overweight and obesity could not be evaluated in our meta-analysis, which require further investigation.

The conclusions of our meta-analysis should be considered under the following limitations. First, the outcome of interest was not uniform in all the included studies. Cases were defined as morbidly obese population, obese population, or combined population of overweight and obesity in different studies. The cutoff used for overweight or obesity differed in studies with the same target population. Second, subgroup analysis was performed to decrease potential between-study heterogeneity; however, limited studies and small sample size in some subgroups may lead to an underpowered result. Third, since insufficient information was provided in the original studies, we failed to fully explore the source of between-study heterogeneity under some circumstances. Last, language was restricted to English and Chinese in the search strategy, which may limit the result.

Conclusions {#s0085}
===========

In conclusion, meta-analyses of currently available studies supported that T allele of Ala55Val polymorphism was associated with an increased risk of overweight and obesity under recessive model, especially for populations of Asian descent; and A allele of -866G/A polymorphism had a protective effect on overweight and obesity, especially for European populations. However, 45-bp insertion/deletion polymorphism is not a susceptibility locus to overweight and obesity. Additional association studies with large sample size and sufficient information allowing powerful stratification analyses are needed to provide more robust evidence to the conclusions. The roles of haplotypes of *UCP2* gene in the pathogenesis of overweight and obesity require to be clarified in future researches.
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###### 

Characteristics of UCP2 gene Ala55Val (rs660339) polymorphism genotype distributions in studies included in this meta-analysis.

  First author       Year   Location   Ethnicity   Genotypes (CC/CT/TT)   T allele frequency (%)   \% of male (case/control)   Mean age (case/control)   *P* for HWE                 
  ------------------ ------ ---------- ----------- ---------------------- ------------------------ --------------------------- ------------------------- ------------- ------------- --------
  Urhammer SA        1997   Denmark    European    41/67/36               56/86/40                 48.3                        45.6                      100/100       Na/Na         0.5209
  Kubota T           1998   Japan      Asian       15/13/14               64/97/57                 48.8                        48.4                      28.6/56.0     47.1/58.2     0.1070
  Yang M             2004   China      Asian       36/45/18               19/29/9                  40.9                        41.2                      Na/Na         Na/Na         0.7066
  Sui Y              2004   China      Asian       41/52/26               82/81/14                 43.7                        30.8                      31.1/38.4     54.2/56.0     0.3266
  Shen LQ            2004   China      Asian       96/34/14               37/9/2                   21.5                        13.5                      50.0/50.0     Na/Na         0.1674
  Xu R               2005   China      Asian       102/193/89             185/356/159              48.3                        48.1                      42.5/33.9     64.1/62.9     0.6236
  Mottagui-Tabar S   2006   Sweden     European    57/136/88              90/227/127               55.5                        54.2                      0/0           Na/Na         0.5318
  Wang TN            2007   Taiwan     Asian       211/104/9              90/24/0                  18.8                        10.5                      38.0/51.9     55.86/58.95   0.2091
  Li Q               2007   China      Asian       44/87/38               77/72/24                 48.2                        34.7                      57.4/58.4     7.7/7.6       0.2842
  Kosuge K           2008   Japan      Asian       56/80/46               91/199/79                47.3                        48.4                      70.9/64.2     50.1/50.7     0.1256
  Wang W             2009   China      Asian       15/23/5                32/13/3                  38.4                        19.8                      67.4/58.1     Na/Na         0.3086
  Yang RR            2012   China      Asian       23/45/12               70/114/38                43.1                        42.8                      Na/Na         Na/Na         0.4670

Na: not available.

###### 

Characteristics of *UCP2* gene 45-bp insertion/deletion polymorphism genotype distributions in studies included in this meta-analysis.

  First author   Year   Location    Ethnicity   Genotypes (DD/ID/II)   I allele frequency (%)   \% of male (case/control)   Mean age (case/control)   *P* for HWE                   
  -------------- ------ ----------- ----------- ---------------------- ------------------------ --------------------------- ------------------------- ------------- --------------- --------
  Dalgaard LT    1999   Denmark     European    371/293/80             177/149/28               30.4                        29.0                      100/100       19--20/19--20   0.6645
  Evans D        2000   Germany     European    145/130/30             286/198/24               31.1                        24.2                      Na/Na         Na/Na           0.1621
  Esterbauer H   2001   Australia   European    179/132/29             117/115/24               27.9                        31.8                      20/25         41.4/40.1       0.5751
  Nieters A      2002   Germany     European    88/58/8                78/57/16                 24.0                        29.5                      37.7/37.7     51.2/51.3       0.2585
  Maestrini S    2003   Italy       European    211/124/25             51/42/10                 24.2                        30.1                      29.2/Na       45.0/Na         0.7537
  Marti A        2004   Spain       European    83/63/11               92/52/6                  27.1                        21.3                      Na/Na         20--60/20--60   0.6875
  Feng QW        2004   China       Asian       75/27/1                138/31/2                 14.1                        10.2                      Na/Na         Na/Na           0.8618
  Hong QR        2005   China       Asian       165/35/1               190/36/4                 9.2                         9.6                       12.7/13.0     63.2/61.3       0.1485
  Ochoa MC       2007   Spain       European    103/71/18              79/76/11                 27.9                        29.5                      51.3/49.3     11.5/11.8       0.1963
  Yiew Sk        2010   Malaysia    Asian       71/14/1                130/37/3                 9.3                         12.6                      Na/Na         Na/Na           0.8454
  Papazoglou D   2012   Greece      European    96/55/7                60/27/4                  21.8                        19.2                      41.1/40.6     50.0/Na         0.6684
  Liu XQ         2012   China       Asian       463/141/12             696/199/15               13.4                        12.6                      51.8/49.8     45.4/44.6       0.8581

Na: not available.

###### 

Characteristics of UCP2 gene -866G/A (rs659366) polymorphism genotype distributions in studies included in this meta-analysis.

  First author    Year   Location    Ethnicity   Genotypes (GG/GA/AA)   A allele frequency (%)   \% of male (case/control)   Mean age (case/control)   *P* for HWE               
  --------------- ------ ----------- ----------- ---------------------- ------------------------ --------------------------- ------------------------- ------------- ----------- --------
  Esterbauer H    2001   Australia   European    54/42/13               221/286/82               31.2                        38.2                      53.2/56.2     53.5/52.8   0.4905
  Esterbauer H    2001   Australia   European    156/140/44             85/127/44                33.5                        42.0                      20.0/25.0     41.4/40.1   0.0642
  Dalgaard LT     2003   Denmark     European    292/322/135            299/369/148              39.5                        40.7                      100/100       20.0/20.0   0.0696
  Schauble N      2003   Germany     European    108/135/34             72/89/27                 36.6                        38.0                      41.5/54.8     14.7/25.5   0.9524
  Mancini FP      2003   Italy       European    96/82/20               183/165/26               30.8                        29.0                      66.7/69.0     36.8/45.0   0.1691
  Xu R            2005   China       Asian       105/197/82             179/357/164              47.0                        48.9                      42.5/33.9     64.1/62.9   0.5881
  Gu GY           2005   China       Asian       5/5/3                  32/73/44                 42.3                        54.0                      69.2/51.7     59.8/52.8   0.8668
  Ochoa MC        2007   Spain       European    79/80/34               59/92/19                 38.3                        38.2                      51.3/49.3     11.5/11.8   0.0573
  Wang TN         2007   Taiwan      Asian       193/115/16             81/28/5                  22.7                        16.7                      38.0/51.9     55.9/59.0   0.2163
  Li JN           2007   China       Asian       10/16/13               21/28/13                 53.8                        43.5                      Na/Na         Na/Na       0.5211
  Shen XJ         2007   China       Asian       32/36/10               45/55/18                 35.9                        38.6                      Na/Na         Na/Na       0.8595
  Kring SI        2008   Denmark     European    88/96/41               114/131/49               39.6                        38.9                      100/100       Na/Na       0.2797
  Lin E           2009   Taiwan      Asian       92/101/29              92/146/47                35.8                        42.1                      48.6/46.3     57.0/57.5   0.3915
  Srivastava N    2010   India       Asian       73/86/41               106/113/21               42.0                        32.3                      Na/Na         Na/Na       0.2346
  Heidari J       2010   Iran        Asian       16/48/11               27/41/7                  46.7                        36.7                      24.0/45.3     44.3/35.9   0.1252
  Zou HY          2011   China       Asian       176/281/133            623/1115/489             46.4                        47.0                      23.7/40.8     55.7/55.8   0.8140
  Oktavianthi S   2012   Indonesia   Asian       60/120/37              127/195/64               44.7                        41.8                      64.5/51.8     47.3/50.1   0.4552
  Andersen G      2012   Denmark     European    583/754/210            1133/1499/521            37.9                        40.3                      Na/Na         Na/Na       0.5028

Na: not available.

###### 

Pooled measures for the associations of the UCP2 Ala55Val, 45-bp insertion/deletion, and -866G/A polymorphisms with overweight and obesity.

  Population                   Inherited model   Before sensitive analysis   After sensitive analysis                             Excluded studies in sensitive analysis                                                                                                                  
  ---------------------------- ----------------- --------------------------- ---------------------------------------------------- ---------------------------------------------------- ------ ----------- ---------------------------------------------------- ------------------- ------ ---------------------------------
  *Ala55Val*                                                                                                                                                                                                                                                                              
  Overall                      Dominant          2011/2752                   1.19 (1.04--1.36)[⁎](#tf0005){ref-type="table-fn"}   1.27 (0.99--1.62)                                    65.4   1799/2531   1.08 (0.94--1.25)                                    1.11 (0.91--1.36)   42.6   [@bb0100], [@bb0225]
                               Recessive         1687/2638                   1.24 (1.06--1.45)[⁎](#tf0005){ref-type="table-fn"}   1.29 (1.06--1.56)[⁎](#tf0005){ref-type="table-fn"}   24.7   --          --                                                   --                  --     --
                               Co-dominant 1     2011/2752                   1.12 (0.97--1.29)                                    1.17 (0.91--1.50)                                    62.0   1799/2531   1.01 (0.87--1.18)                                    1.02 (0.84--1.25)   35.1   [@bb0100], [@bb0225]
                               Co-dominant 2     1687/2638                   1.26 (1.05--1.52)[⁎](#tf0005){ref-type="table-fn"}   1.38 (1.03--1.84)[⁎](#tf0005){ref-type="table-fn"}   51.3   1568/2461   1.18 (0.97--1.42)                                    1.22 (0.96--1.54)   25.4   [@bb0205]
                               Additive          2011/2752                   1.24 (1.09--1.41)[⁎](#tf0005){ref-type="table-fn"}   1.34 (1.04--1.72)[⁎](#tf0005){ref-type="table-fn"}   69.5   1475/2417   1.07 (0.92--1.23)                                    1.09 (0.90--1.31)   33.9   [@bb0100], [@bb0220], [@bb0225]
                               Over-dominant     2011/2752                   1.00 (0.89--1.13)                                    1.04 (0.85--1.27)                                    54.6   1968/2704   0.98 (0.86--1.11)                                    0.99 (0.83--1.19)   43.5   [@bb0225]
                               Allelic           2011/2752                   1.17 (1.07--1.27)[⁎](#tf0005){ref-type="table-fn"}   1.25 (1.07--1.48)[⁎](#tf0005){ref-type="table-fn"}   64.6   1723/2402   1.08 (0.98--1.19)                                    1.14 (0.98--1.32)   46.2   [@bb0100], [@bb0205]
  Asian                        Dominant          1586/2126                   1.24 (1.06--1.44)[⁎](#tf0005){ref-type="table-fn"}   1.34 (0.99--1.81)                                    70.7   1050/1791   1.02 (0.85--1.21)                                    1.03 (0.82--1.31)   35.0   [@bb0100], [@bb0220], [@bb0225]
                               Recessive         1262/2012                   1.28 (1.06--1.55)[⁎](#tf0005){ref-type="table-fn"}   1.39 (1.06--1.82)[⁎](#tf0005){ref-type="table-fn"}   37.8   --          --                                                   --                  --     --
                               Co-dominant 1     1586/2126                   1.15 (0.98--1.36)                                    1.22 (0.90--1.67)                                    68.0   1192/1536   1.12 (0.92--1.36)                                    1.13 (0.88--1.45)   29.9   [@bb0080], [@bb0100], [@bb0225]
                               Co-dominant 2     1262/2012                   1.31 (1.06--1.63)[⁎](#tf0005){ref-type="table-fn"}   1.50 (1.01--2.20)[⁎](#tf0005){ref-type="table-fn"}   59.9   1143/1835   1.19 (0.95--1.50)                                    1.28 (0.92--1.80)   41.2   [@bb0205]
                               Additive          1586/2126                   1.29 (1.11--1.50)[⁎](#tf0005){ref-type="table-fn"}   1.41 (1.04--1.93)[⁎](#tf0005){ref-type="table-fn"}   74.0   1050/1791   1.07 (0.90--1.26)                                    1.10 (0.85--1.43)   49.9   [@bb0100], [@bb0220], [@bb0225]
                               Over-dominant     1586/2126                   1.03 (0.89--1.19)                                    1.09 (0.84--1.40)                                    61.8   1361/1709   1.08 (0.92--1.27)                                    1.10 (0.88--1.37)   39.2   [@bb0080], [@bb0225]
                               Allelic           1586/2126                   1.20 (1.08--1.33)[⁎](#tf0005){ref-type="table-fn"}   1.32 (1.07--1.63)[⁎](#tf0005){ref-type="table-fn"}   64.6   974/1662    1.04 (0.93--1.18)                                    1.09 (0.91--1.30)   39.7   [@bb0100], [@bb0205], [@bb0220]
  European                     Dominant          425/626                     1.04 (0.78--1.40)                                    1.04 (0.78--1.40)                                    0.0    --          --                                                   --                  --     --
                               Recessive         425/626                     1.15 (0.87--1.52)                                    1.15 (0.87--1.52)                                    0.0    --          --                                                   --                  --     --
                               Co-dominant 1     425/626                     0.99 (0.72--1.35)                                    0.99 (0.72--1.35)                                    0.0    --          --                                                   --                  --     --
                               Co-dominant 2     425/626                     1.14 (0.80--1.61)                                    1.14 (0.80--1.61)                                    0.0    --          --                                                   --                  --     --
                               Additive          425/626                     1.07 (0.80--1.42)                                    1.07 (0.80--1.42)                                    0.0    --          --                                                   --                  --     --
                               Over-dominant     425/626                     0.92 (0.72--1.18)                                    0.92 (0.72--1.18)                                    0.0    --          --                                                   --                  --     --
                               Allelic           425/626                     1.07 (0.90--1.28)                                    1.07 (0.90--1.28)                                    0.0    --          --                                                   --                  --     --
                                                                                                                                                                                                                                                                                          
  *45-bp insertion/deletion*                                                                                                                                                                                                                                                              
  Overall                      Dominant          3416/3260                   1.02 (0.92--1.13)                                    1.01 (0.86--1.17)                                    45.7   --          --                                                   --                  --     --
                               Recessive         3416/3260                   1.19 (0.95--1.49)                                    1.13 (0.85--1.51)                                    28.6   --          --                                                   --                  --     --
                               Co-dominant 1     3416/3260                   1.00 (0.89--1.12)                                    0.99 (0.86--1.15)                                    33.4   --          --                                                   --                  --     --
                               Co-dominant 2     3416/3260                   1.16 (0.92--1.46)                                    1.08 (0.78--1.51)                                    41.4   --          --                                                   --                  --     --
                               Additive          3416/3260                   1.04 (0.93--1.15)                                    1.01 (0.86--1.19)                                    56.2   3111/2752   0.97 (0.87--1.09)                                    0.96 (0.83--1.12)   38.7   [@bb0040]
                               Over-dominant     3416/3260                   0.98 (0.88--1.09)                                    0.98 (0.86--1.11)                                    20.4                                                                                               --
                               Allelic           3416/3260                   1.04 (0.95--1.13)                                    1.02 (0.89--1.17)                                    53.0   3111/2752   0.98 (0.90--1.08)                                    0.98 (0.87--1.10)   32.2   [@bb0040]
  Asian                        Dominant          1006/1481                   1.07 (0.88--1.30)                                    1.07 (0.86--1.34)                                    11.8   --          --                                                   --                  --     --
                               Recessive         1006/1481                   0.96 (0.50--1.87)                                    0.96 (0.50--1.87)                                    0.0    --          --                                                   --                  --     --
                               Co-dominant 1     1006/1481                   1.08 (0.89--1.32)                                    1.09 (0.87--1.36)                                    11.8   --          --                                                   --                  --     --
                               Co-dominant 2     1006/1481                   0.98 (0.50--1.90)                                    0.98 (0.50--1.90)                                    0.0    --          --                                                   --                  --     --
                               Additive          1006/1481                   1.06 (0.88--1.28)                                    1.06 (0.84--1.32)                                    15.8   --          --                                                   --                  --     --
                               Over-dominant     1006/1481                   1.08 (0.89--1.32)                                    1.09 (0.87--1.36)                                    11.4   --          --                                                   --                  --     --
                               Allelic           1006/1481                   1.05 (0.89--1.26)                                    1.05 (0.87--1.27)                                    5.8    --          --                                                   --                  --     --
  European                     Dominant          2410/1779                   1.00 (0.88--1.13)                                    0.98 (0.80--1.20)                                    57.5   2105/1271   0.91 (0.79--1.05)                                    0.91 (0.76--1.09)   33.7   [@bb0040]
                               Recessive         2410/1779                   1.22 (0.96--1.55)                                    1.16 (0.82--1.65)                                    47.6   --          --                                                   --                  --     --
                               Co-dominant 1     2410/1779                   0.96 (0.84--1.10)                                    0.96 (0.80--1.15)                                    42.5   --          --                                                   --                  --     --
                               Co-dominant 2     2410/1779                   1.18 (0.92--1.51)                                    1.12 (0.74--1.68)                                    58.5   2105/1271   1.00 (0.76--1.32)                                    0.97 (0.68--1.39)   34.1   [@bb0040]
                               Additive          2410/1779                   1.02 (0.91--1.16)                                    1.00 (0.80--1.25)                                    67.3   2105/1271   0.93 (0.81--1.06)                                    0.92 (0.76--1.12)   47.4   [@bb0040]
                               Over-dominant     2410/1779                   0.94 (0.82--1.07)                                    0.94 (0.81--1.09)                                    22.3   --          --                                                   --                  --     
                               Allelic           2410/1779                   1.03 (0.94--1.14)                                    1.01 (0.85--1.21)                                    65.3   2105/1271   0.96 (0.86--1.07)                                    0.95 (0.81--1.11)   44.1   [@bb0040]
                                                                                                                                                                                                                                                                                          
  -866G/A                                                                                                                                                                                                                                                                                 
  Overall                      Dominant          5780/10,196                 0.93 (0.86--0.99)[⁎](#tf0005){ref-type="table-fn"}   0.94 (0.83--1.06)                                    52.7   5440/9940   0.95 (0.88--1.02)                                    0.97 (0.86--1.02)   43.9   [@bb0035]
                               Recessive         5780/10,196                 0.96 (0.88--1.05)                                    1.02 (0.88--1.18)                                    44.9   --          --                                                   --                         --
                               Co-dominant 1     5780/10,196                 0.93 (0.86--1.00)                                    0.92 (0.82--1.03)                                    44.3   --          --                                                   --                         --
                               Co-dominant 2     5780/10,196                 0.91 (0.83--1.01)                                    0.98 (0.82--1.17)                                    52.9   5580/9956   0.88 (0.80--0.98)[⁎](#tf0005){ref-type="table-fn"}   0.91 (0.79--1.05)   28.2   [@bb0200]
                               Additive          5780/10,196                 0.93 (0.86--0.99)[⁎](#tf0005){ref-type="table-fn"}   0.95 (0.84--1.08)                                    60.7   5240/9700   0.93 (0.86--1.00)                                    0.95 (0.85--1.06)   44.7   [@bb0035], [@bb0200]
                               Over-dominant     5780/10,196                 0.95 (0.89--1.02)                                    0.93 (0.85--1.03)                                    32.6   --          --                                                   --                  --     --
                               Allelic           5780/10,196                 0.95 (0.91--1.00)                                    0.98 (0.90--1.07)                                    57.6   5580/9956   0.94 (0.89--0.99)[⁎](#tf0005){ref-type="table-fn"}   0.95 (0.88--1.03)   44.4   [@bb0200]
  Asian                        Dominant          2142/4356                   1.01 (0.90--1.14)                                    1.07 (0.87--1.32)                                    58.1   1596/3957   1.03 (0.90--1.17)                                    1.08 (0.88--1.32)   42.4   [@bb0110], [@bb0220]
                               Recessive         2142/4356                   1.05 (0.91--1.21)                                    1.11 (0.88--1.40)                                    45.8   --          --                                                   --                  --     --
                               Co-dominant 1     2142/4356                   1.00 (0.88--1.13)                                    1.04 (0.86--1.26)                                    45.7   --          --                                                   --                  --     --
                               Co-dominant 2     2142/4356                   1.03 (0.88--1.22)                                    1.13 (0.83--1.54)                                    59.4   1942/4116   0.95 (0.80--1.13)                                    0.97 (0.77--1.21)   24.6   [@bb0200]
                               Additive          2142/4356                   1.03 (0.91--1.15)                                    1.10 (0.87--1.37)                                    66.1   1396/3717   0.99 (0.87--1.13)                                    1.04 (0.83--1.30)   45.4   [@bb0110], [@bb0200], [@bb0220]
                               Over-dominant     2142/4356                   0.98 (0.88--1.10)                                    1.00 (0.87--1.14)                                    19.8   --          --                                                   --                  --     --
                               Allelic           2142/4356                   1.02 (0.95--1.11)                                    1.08 (0.92--1.26)                                    63.6   1720/3831   1.02 (0.93--1.11)                                    1.06 (0.92--1.22)   41.5   [@bb0110], [@bb0200]
  European                     Dominant          3638/5840                   0.88 (0.81--0.96)[⁎](#tf0005){ref-type="table-fn"}   0.86 (0.75--0.97)[⁎](#tf0005){ref-type="table-fn"}   36.8   --          --                                                   --                  --     --
                               Recessive         3638/5840                   0.90 (0.80--1.01)                                    0.95 (0.79--1.14)                                    39.1   --          --                                                   --                  --     --
                               Co-dominant 1     3638/5840                   0.89 (0.81--0.98)[⁎](#tf0005){ref-type="table-fn"}   0.85 (0.73--0.98)[⁎](#tf0005){ref-type="table-fn"}   42.2   --          --                                                   --                  --     --
                               Co-dominant 2     3638/5840                   0.85 (0.74--0.94)[⁎](#tf0005){ref-type="table-fn"}   0.87 (0.72--1.05)                                    33.3   --          --                                                   --                  --     --
                               Additive          3638/5840                   0.88 (0.80--0.95)[⁎](#tf0005){ref-type="table-fn"}   0.86 (0.76--0.98)[⁎](#tf0005){ref-type="table-fn"}   41.5   --          --                                                   --                  --     --
                               Over-dominant     3638/5840                   0.94 (0.86--1.02)                                    0.88 (0.76--1.01)                                    48.5   --          --                                                   --                  --     --
                               Allelic           3638/5840                   0.91 (0.86--0.97)[⁎](#tf0005){ref-type="table-fn"}   0.91 (0.84--0.99)[⁎](#tf0005){ref-type="table-fn"}   31.5   --          --                                                   --                  --     --

Dominant model: CT+TT vs. CC for Ala55Val, ID+II vs. DD for 45-bp insertion/deletion, and GA+AA vs. GG for -866G/A.

Recessive model: TT vs. CT+CC for Ala55Val, II vs. ID+DD for 45-bp insertion/deletion, and AA vs. GA+GG for -866G/A.

Co-dominant 1 model: CT vs. CC for Ala55Val, ID vs. DD for 45-bp insertion/deletion, and GA vs. GG for -866G/A.

Co-dominant 2 model: TT vs. CC for Ala55Val, II vs. DD for 45-bp insertion/deletion, and AA vs. GG for -866G/A.

Additive model: 2TT+CT vs. CC for Ala55Val, 2II+ID vs. DD for 45-bp insertion/deletion, and 2AA+GA vs. GG for -866G/A.

Over-dominant model: CT vs. CC+TT for Ala55Val, ID vs. II+DD for 45-bp insertion/deletion, and GA vs. AA+GG for -866G/A.

Allelic model: T vs. C for Ala55Val, I vs. D for 45-bp insertion/deletion, and A vs. G for -866G/A.

DHWE: deviating from Hardy--Weinberg equilibrium.

FEM: fixed effect model; REM: random effect model.

*P* \< 0.05.
